Luncheon Seminar

LS1-3

New therapeutic approaches in follicular lymphoma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Kensei Tobinai (National Cancer Center Hospital)

Sponsors: Chugai Pharmaceutical Co., Ltd./Nippon Shinyaku Co., Ltd.

Luncheon Seminar

LS1-4

New Treatment Strategy for Relapse and Refractory Multiple Myeloma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Takaaki Chou (Niigata Cancer Center Hospital Hematology/Oncology)

Sponsor: Takeda Pharmaceutical Company Limited

Luncheon Seminar

LS1-5

Management of Hepatitis B Virus Reactivation during and/or following Immunosuppressive Therapies and Chemotherapies

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Takahiro Fukuda (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)

Sponsor: Gilead Sciences K.K.

Luncheon Seminar

LS1-6

Myeloproliferative neoplasms diagnosis based on pathological and mutational criteria

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Fumihiko Kimura (Division of Hematology, Department of Internal Medicine, National Defense Medical College)

Sponsors: Novartis Pharma K.K./SYSMEX CORPORATION

Luncheon Seminar

LS1-7

Recent Therapeutic Strategy in Peripheral T-cell Lymphoma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Kazuhito Yamamoto (Department of Hematology and Cell Therapy, Aichi Cancer Center)

Sponsor: Meiji Seika Pharma Co., Ltd

Luncheon Seminar

LS1-8

Past, present and future management of CMV - Emerging role of prophylactic letermovir -

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine)

Sponsor: MSD K.K.

Luncheon Seminar

LS1-9

Mantle cell lymphoma: Update on diagnosis, risk-stratification, and clinical management

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Hirokazu Nagai (Department of Hematology and Oncology Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center)

Sponsor: Janssen Pharmaceutical K.K.

Luncheon Seminar

LS1-10

Immunomodulatory effects of TKI treatment and links to treatment response in CML

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Toshihiro Miyamoto (Department of Medicine and Biosystemic Science, Kyusyu University Graduate School of Medical Science)

Sponsor: Bristol-Myers Squibb K.K.

Luncheon Seminar

LS1-11

APL - Pathology of coagulopathy and clinical approach -

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Norio Asou (Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan)

Sponsor: Asahi Kasei Pharma Corporation

Luncheon Seminar

LS1-12

Treatment strategy for autologous stem cell transplantation: MOZOBIL® centered strategy

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Kazutaka Sunami (Department of Hematology, National Hospital Organization Okayama Medical Center)

Sponsor: Sanofi K.K.